darinaparsin

DRUG4 trials

Sponsors

Alaunos Therapeutics

Conditions

Advanced Solid TumorsBone Marrow NeoplasmsHEPATOCELLULAR CARCINOMAHematologic NeoplasmsLymphomaNon-Hodgkin's Lymphoma

Phase 1

Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

WithdrawnNCT01139359

Alaunos TherapeuticsLymphoma

Start: 2010-06-30End: 2011-06-30Updated: 2012-07-19

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

CompletedNCT01139346

Alaunos TherapeuticsAdvanced Solid Tumors

Start: 2010-06-30End: 2012-04-30Updated: 2012-07-19

Phase 2

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

CompletedNCT00421213

Alaunos TherapeuticsBone Marrow Neoplasms, Hematologic Neoplasms, Non-Hodgkin's Lymphoma

Start: 2006-12-31End: 2012-04-30Updated: 2012-07-19

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

Alaunos TherapeuticsHEPATOCELLULAR CARCINOMA

Start: 2007-01-31End: 2013-12-31Updated: 2013-11-14